Biotech · Private company · Lancaster, PA, US

Lynthera Corporation

Track this companyFree. Adds Lynthera Corporation to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Drug delivery platform for ocular allergy therapyFiscal year 2025 · $900KNIH RePORTER 5R44EY033611-03 · fetched Nov 12, 2026
Drug delivery platform for ocular allergy therapyFiscal year 2024 · $900KNIH RePORTER 2R44EY033611-02 · fetched Nov 12, 2026
I-Corps for Novel Formulation Technology for Sustained Release NaloxoneFiscal year 2024 · $55KNIH RePORTER 3R43DA058477-01A1S1 · fetched Nov 12, 2026
Sustained delivery technology for Cyclosporine A in the treatment of autoimmune responseFiscal year 2024 · $795KNIH RePORTER 5R44EY032424-03 · fetched Nov 12, 2026